What is NanoSphere Health Sciences Inc. (NSHSF) stock price today?

NanoSphere Health Sciences Inc. (NSHSF) is currently trading at $0.01, up 0% today.

What is NSHSF P/E ratio?

NanoSphere Health Sciences Inc.'s P/E ratio is -1.78. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is NSHSF return on equity (ROE)?

NanoSphere Health Sciences Inc.'s return on equity (ROE) is 6.14%. ROE measures net income relative to shareholders' equity. Shareholders' equity is negative, so ROE is not a meaningful measure for this company.

What is NanoSphere Health Sciences Inc.'s market cap?

NanoSphere Health Sciences Inc. has a market capitalization of $102752.

OTC · Biotechnology

NanoSphere Health Sciences Inc. (NSHSF) Stock

$0.01 +0.00% OTC: NSHSF Healthcare

NanoSphere Health Sciences Inc. operates as a nano-biotechnology enterprise, concentrating on the provision of biologically active compounds throughout both the United States and Canada.

Valuation

Metric	Value
Price	$0.01
Market Cap	$102752
P/E Ratio	-1.78
P/B Ratio	-0.11
P/S Ratio	0.00
EPS (TTM)	$-0.01
52-Week High	$0.02
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	6.14%
ROA	-494.03%
ROCE	13.26%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	-0.04
Current Ratio	0.01

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	$0	$0	$0
Operating Profit	$0	$0	$0	$0	$0
Net Profit	$0	$0	$0	$0	$0
EPS	$-0.05	$-0.03	$-0.02	$0.02	$-0.01
Op Margin	—	—	—	—	—

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$0	$0	$0	$0	$0
Total Liabilities	$1.0M	$1.0M	$2.0M	$1.0M	$1.0M
Cash	$0	$0	$0	$0	$0
Borrowings	$0	$0	$0	$0	$0

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$0	$0	$0	$0	$0
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$0	$0	$0	$0	$0
Free Cash Flow	$0	$0	$0	$0	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.01
EV / EBITDA	-0.94
FCF Yield	-16.67%
Quick Ratio	0.01
Interest Coverage	-42.48
Return 1Y	-50.00%
Return 3Y	-33.33%
Return 5Y	—

Ownership

Insiders Held32.29%

Institutions Held0.00%

Institutions Float Held0.00%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BETRFBetterLife Pharma Inc.	$0.15	-7.50%	-16.80	$23.96M	0.00%
BIXTBioxytran, Inc.	$0.02	+1.49%	-0.91	$2.37M	0.00%
BVAXFBioVaxys Technology Corp.	$0.11	+0.09%	-0.59	$3.27M	0.00%
CHMMFChimeric Therapeutics Limited	$0.10	+0.00%	-0.06	$4.10M	0.00%
CPMVMosaic ImmunoEngineering Inc.	$0.55	+65.36%	-6.11	$3.98M	0.00%

About NanoSphere Health Sciences Inc.

NanoSphere Health Sciences Inc. operates as a nano-biotechnology enterprise, concentrating on the provision of biologically active compounds throughout both the United States and Canada. Its principal offering is the NanoSphere Deliver System, an advanced platform that leverages nanotechnology to enhance the biological absorption of supplements, nutraceuticals, and non-prescription drugs. This innovative system serves various industries, including cannabis, pharmaceuticals, and animal health. Established in 2005, the company maintains its corporate headquarters in Vancouver, Canada.

NanoSphere Health Sciences Inc. is headquartered in CA.

NanoSphere Health Sciences Inc. (NSHSF) stock trades at $0.01 with a market capitalization of $102752. The stock is valued at a negative price-to-earnings (P/E) ratio of -1.78, reflecting a net loss over the last twelve months, a negative price-to-book of -0.11, reflecting negative shareholders' equity, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.02, and currently trades 50.0% below its 52-week high.

On profitability, NanoSphere Health Sciences Inc. generates a return on equity (ROE) of 6.14% (not meaningful, as shareholders' equity is negative), return on capital employed of 13.26%.

Official website: www.nanospherehealth.com